NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

全球基因面板市場:按技術、設計、應用、最終用戶分列的市場規模、份額、前景和機會分析(2021-2028)

Gene Panel Market, by Technique, by Design, by Application, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

出版商 Coherent Market Insights 商品編碼 1021675
出版日期 內容資訊 英文 160 Pages
商品交期: 2-3個工作天內
價格
全球基因面板市場:按技術、設計、應用、最終用戶分列的市場規模、份額、前景和機會分析(2021-2028) Gene Panel Market, by Technique, by Design, by Application, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028
出版日期: 2021年07月28日內容資訊: 英文 160 Pages
簡介

基因面板是一種特殊的診斷工具,用於同時評估與癌症和心肌病等疾病相關的多個基因的突變。通過使用基因面板,用戶可以免費獲得結果。基因面板有助於分析 BRCA1 等基因,以檢測可能導致癌症的突變。來自血液、肌肉和唾液的 DNA 可用於測試基因組。肌肉張力下降、癲癇、身材矮小等是可以使用基因組測試來診斷的疾病。 DNA 測序技術的快速發展使基因面板更加高效、經濟和靈活。

市場動態

市場參與者正在進行臨床試驗,探索使用基因面板診斷各種遺傳性疾病的可能性,這可能有助於預測期內基因面板市場的增長。例如,2020 年 11 月,法國波爾多大學醫院啟動了一項觀察性臨床試驗,旨在引入下一代測序基因面板,用於診斷不完全形式的色素缺乏症。這項研究證實了 NGS 基因面板在克服白化病診斷中面臨的挑戰方面的有用性,白化病幾乎沒有可觀察到的眼科症狀。該研究由 100 名受試者組成,預計將於 2022 年 3 月完成。

市場准入公司正專注於產品發佈,這有望加強其在全球基因面板市場的地位。例如,2018 年 6 月,美國科學設備製造商 Thermo Fisher Scientific Inc. 宣佈 Ion AmpliSeq HD 技術作為下一個目標基因序列的基於擴增子的文庫。該技術允許用戶通過從與特定疾病相關的基因庫中選擇合適的基因序列,檢測腫瘤 RNA 或 DNA 中不常見的等位基因來定制他們自己的基因面板。

本報告對全球基因面板市場進行研究和分析,並提供有關市場概況、市場規模和預測、細分市場分析、地區市場分析、競爭形勢等方面的系統信息。

目錄

第 1 章調查目標/先決條件

第 2 章市場概覽

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
    • 市場細分:按技術
    • 市場細分:按設計
    • 市場細分:按應用
    • 市場細分:按最終用戶
    • 市場細分:按地區
  • 相干機會圖 (COM)

第 3 章市場動態、監管和趨勢分析

  • 市場動態
    • 增長因素
    • 抑制因素
    • 市場機會
  • 影響分析
  • 波特分析
  • 行業趨勢
  • 管道分析
  • 主要亮點
  • 流行病學
  • 價格分析
  • 兌換場景
  • 監管場景
  • 全球供應鏈分析

第 4 章 COVID-19 影響分析

  • COVID-19 流行病學
  • COVID-19 對基因組供需的影響
  • Covid-19 對基因面板市場的影響

第 5 章全球基因面板市場:按技術,2017-2028(100 萬美元)

  • 簡介
  • 擴增子鹼基
  • 雜交基礎

第 6 章全球基因面板市場:按設計,2017-2028(100 萬美元)

  • 簡介
  • 預先設計的基因面板
  • 定制基因面板

第 7 章全球基因面板市場:按應用,2017-2028(100 萬美元)

  • 簡介
  • 藥物基因組學
  • 先天性疾病的診斷
  • 癌症風險評估
  • 其他

第 8 章全球基因面板市場:按最終用戶,2017-2028(100 萬美元)

  • 簡介
  • 研究/學術機構
  • 醫院和診斷實驗室
  • 生物技術和製藥公司

第 9 章全球基因面板市場:區域,2017-2028(100 萬美元)

  • 簡介
  • 北美
  • 拉丁美洲
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第 10 章競爭形勢

  • 公司簡介
    • Thermo Fisher Scientific Inc.
    • BGI
    • GENEWIZ, Inc.
    • GATC Biotech
    • Novogene Co., Ltd.
    • QIAGEN
    • Integrated DNA Technologies, Inc.
    • Illumina, Inc.
    • Agilent Technologies, Inc.
    • Eurofins Scientific
    • F. Hoffmann-La Roche Ltd
    • Personalis Inc.
    • GeneDx Inc.
    • Invitae Corporation
  • 分析師觀點

第 11 章 章節

目錄

Gene panels are specialized diagnostic tools used to assess multiple genes at once for mutations related to diseases such as cancer, cardiomyopathy, and others. Gene panels enable the users to obtain results at a reduced cost and time. Gene panels are useful in sequencing genes such as BRCA1 to detect mutations that may lead to cancer. DNA sample from blood, muscle or saliva can be used in gene panel testing. Low muscle tone, epilepsy, and short stature are few conditions which can be diagnosed using gene panel tests. Rapid research in DNA sequencing technology has led to the advancement of gene panels making them more efficient, economical, and flexible.

Market Dynamics

Market players are conducting clinical trials for exploring the potential uses of gene panels for diagnosis of a number of genetic disorders, which could contribute to the growth of the gene panel market over the forecast period. For instance, in November 2020 Bordeaux University Hospital, France, initiated an observational clinical study for implementation of a next generation sequencing gene panel for diagnosis of incomplete forms of albinism. This study identifies the usability of NGS gene panel in overcoming the challenges faced in identification of ocular albinism as it does not show many observable ophthalmic signs. This study comprises of 100 participants and is expected to be completed by March 2022.

Market players are focusing on launch of products, which is expected to strengthen their position in the global gene panel market. For instance, in June 2018, Thermo Fisher Scientific Inc., an American scientific instrumentation company, launched Ion AmpliSeq HD technology as an amplicon-based library for targeted next gene sequencing, it enables the user to customize one's own gene panel by selecting the appropriate gene sequences from the gene library which are associated with a particular disease and detect low-frequency alleles in tumor RNA or DNA.

Key features of the study:

  • This report provides an in-depth analysis of global gene panel market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2021-2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
  • It profiles leading players in the global gene panel market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study include Thermo Fisher Scientific Inc., BGI, GENEWIZ, Inc., GATC Biotech, Novogene Co., Ltd., QIAGEN, Integrated DNA Technologies, Inc., Illumina Inc., Agilent Technologies, Inc., Eurofins Scientific, F. Hoffmann-La Roche Ltd, Personalis Inc., GeneDx Inc., and Invitae Corporation
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
  • The global gene panel market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision making through various strategy matrices used in analyzing the gene panel market

Detailed Segmentation:

  • Global Gene Panel Market, By Technique:
    • Amplicon-Based
    • Hybridization-Based
  • Global Gene Panel Market, By Design:
    • Predesigned Gene Panels
    • Customized Gene Panels
  • Global Gene Panel Market, By Application:
    • Pharmacogenetics
    • Diagnosis of Congenital Disorders
    • Cancer Risk Assessment
    • Others
  • Global Gene Panel Market, By End User:
    • Research and Academic Institutes
    • Hospital and Diagnostic Laboratories
    • Biotechnology and Pharmaceutical Companies
  • Global Gene Panel Market, By Region:
    • North America
  • By Technique:
    • Amplicon-Based
    • Hybridization-Based
  • By Design:
    • Predesigned Gene Panels
    • Customized Gene Panels
  • By Application:
    • Pharmacogenetics
    • Diagnosis of Congenital Disorders
    • Cancer Risk Assessment
    • Others
  • By End User:
    • Research and Academic Institutes
    • Hospital and Diagnostic Laboratories
    • Biotechnology and Pharmaceutical Companies
  • By Country:
    • U.S.
    • Canada
    • Latin America
  • By Technique:
    • Amplicon-Based
    • Hybridization-Based
  • By Design:
    • Predesigned Gene Panels
    • Customized Gene Panels
  • By Application:
    • Pharmacogenetics
    • Diagnosis of Congenital Disorders
    • Cancer Risk Assessment
    • Others
  • By End User:
    • Research and Academic Institutes
    • Hospital and Diagnostic Laboratories
    • Biotechnology and Pharmaceutical Companies
  • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
  • By Technique:
    • Amplicon-Based
    • Hybridization-Based
  • By Design:
    • Predesigned Gene Panels
    • Customized Gene Panels
  • By Application:
    • Pharmacogenetics
    • Diagnosis of Congenital Disorders
    • Cancer Risk Assessment
    • Others
  • By End User:
    • Research and Academic Institutes
    • Hospital and Diagnostic Laboratories
    • Biotechnology and Pharmaceutical Companies
  • By Country:
    • U.K.
    • Germany
    • Italy
    • Spain
    • France
    • Russia
    • Rest of Europe
    • Asia Pacific
  • By Technique:
    • Amplicon-Based
    • Hybridization-Based
  • By Design:
    • Predesigned Gene Panels
    • Customized Gene Panels
  • By Application:
    • Pharmacogenetics
    • Diagnosis of Congenital Disorders
    • Cancer Risk Assessment
    • Others
  • By End User:
    • Research and Academic Institutes
    • Hospital and Diagnostic Laboratories
    • Biotechnology and Pharmaceutical Companies
  • By Country
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
  • By Technique:
    • Amplicon-Based
    • Hybridization-Based
  • By Design:
    • Predesigned Gene Panels
    • Customized Gene Panels
  • By Application:
    • Pharmacogenetics
    • Diagnosis of Congenital Disorders
    • Cancer Risk Assessment
    • Others
  • By End User:
    • Research and Academic Institutes
    • Hospital and Diagnostic Laboratories
    • Biotechnology and Pharmaceutical Companies
  • By Country:
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
  • By Technique:
    • Amplicon-Based
    • Hybridization-Based
  • By Design:
    • Predesigned Gene Panels
    • Customized Gene Panels
  • By Application:
    • Pharmacogenetics
    • Diagnosis of Congenital Disorders
    • Cancer Risk Assessment
    • Others
  • By End User:
    • Research and Academic Institutes
    • Hospital and Diagnostic Laboratories
    • Biotechnology and Pharmaceutical Companies
  • By Country/Region:
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
  • Thermo Fisher Scientific Inc.*
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • BGI
  • GENEWIZ, Inc.
  • GATC Biotech
  • Novogene Co., Ltd.
  • QIAGEN
  • Integrated DNA Technologies, Inc.
  • Illumina, Inc.
  • Agilent Technologies, Inc.
  • Eurofins Scientific
  • F. Hoffmann-La Roche Ltd
  • Personalis Inc.
  • GeneDx Inc.
  • Invitae Corporation

* marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Technique
    • Market Snippet, By Design
    • Market Snippet, By Application
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Porter's Analysis
  • Industry Trends
  • Pipeline Analysis
  • Key Highlights
  • Epidemiology
  • Pricing Analysis
  • Reimbursement Scenario
  • Regulatory Scenario
  • Global Supply Chain Analysis

4. COVID - 19 Impact Analysis

  • COVID-19 Epidemiology
  • Impact of COVID-19 on Demand and Supply of Gene Panel
  • Impact of Covid-19 on the Gene Panel Market

5. Global Gene Panel Market, By Technique, 2017-2028 (US$ Million)

  • Introduction
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2018 - 2028
    • Segment Trends
  • Amplicon-Based
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Hybridization-Based
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

6. Global Gene Panel Market, By Design, 2017 - 2028 (US$ Million)

  • Introduction
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2018 - 2028
    • Segment Trends
  • Predesigned Gene Panels
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Customized Gene Panels
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

7. Global Gene Panel Market, By Application, 2017 - 2028 (US$ Million)

  • Introduction
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2018 - 2028
    • Segment Trends
  • Pharmacogenetics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Diagnosis of Congenital Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Cancer Risk Assessment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

8. Global Gene Panel Market, By End User, 2017 - 2028 (US$ Million)

  • Introduction
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2018 - 2028
    • Segment Trends
  • Research and Academic Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Hospital and Diagnostic Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Biotechnology and Pharmaceutical Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

9. Global Gene Panel Market, By Region, 2017 - 2028 (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, For Regions, 2018 - 2028
    • Regional Trends
  • North America
    • Market Size and Forecast, By Technique, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Design, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Technique, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Design, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Technique, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Design, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Technique, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Design, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Technique, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Design, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Technique, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Design, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Country/Region, 2017 - 2028 (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

10. Competitive Landscape

  • Company Profiles
    • Thermo Fisher Scientific Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • BGI
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • GENEWIZ, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • GATC Biotech
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Novogene Co., Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • QIAGEN
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Integrated DNA Technologies, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Illumina, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Agilent Technologies, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Eurofins Scientific
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • F. Hoffmann-La Roche Ltd
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Personalis Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • GeneDx Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Invitae Corporation
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
  • Analyst Views

11. Section

  • References
  • Research Methodology
  • About us and Sales Contact